Literature DB >> 2633245

[Cholesteatoma and labyrinthine fistula].

C Martin, H Martin, J M Prades, X Perron, P Bertholon.   

Abstract

43 cases of large labyrinthic fistulas caused by a cholesteatoma of the middle ear were studied (33 External Semi-circular Canal fistulas, 4 External Semi-circular Canal amputations with opening of the vestibule, 3 of the promontory, 2 of the oval window, 1 of the Semi-circular Canal). The audiometric, preoperative, radiological data was analyzed. The radiological exam is often disappointing for the average-sized fistulas. Preoperative labyrinthization is moderate for External Semi-circular Canal fistulas and even for certain vestibular amputations; it is often incomplete in the other locations. Systematic exeresis of the cholesteatoma matrix is recommended by the authors, at least for the External Semi-circular Canal fistulas as it is not generally accompanied by aggravation of the bony curve. In the other locations, surprising auditory preservations were observed. In conclusion, the presence of External Semi-circular Canal fistulas should not be a counter-indication for carrying out a ossiculoplasty.

Entities:  

Mesh:

Year:  1989        PMID: 2633245

Source DB:  PubMed          Journal:  Rev Laryngol Otol Rhinol (Bord)        ISSN: 0035-1334


  3 in total

1.  Computed tomography in chronic suppurative otitis media: value in surgical planning.

Authors:  Garg Payal; Kulshreshtha Pranjal; Motwani Gul; M K Mittal; A K Rai
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-05

2.  Preserving bone conduction in patients with labyrinthine fistula.

Authors:  Anamaria Gocea; Brigida Martinez-Vidal; Charlotte Panuschka; Pilar Epprecht; Miguel Caballero; Manuel Bernal-Sprekelsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-14       Impact factor: 2.503

3.  Prognostic indicators of hearing after complete resection of cholesteatoma causing a labyrinthine fistula.

Authors:  Marie-France Stephenson; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-09       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.